China Pharma Holdings Inc (CPHI)
China Pharma Holdings Inc. is a common stock listing on the NYSE for a healthcare company focused on pharmaceuticals. Based in Haikou, People’s Republic of China, the company develops, manufactures, and markets human pharmaceutical products for the domestic Chinese market. Its portfolio includes dry powder and liquid injectables, tablets, capsules, and cephalosporin oral solutions. The company’s products are used across a range of therapeutic areas, including neurological, cardiovascular, respiratory, anti-infective, digestive, and oncology-related supportive care applications. China Pharma also supplies items such as sanitizers, masks, and a food supplement. Its products are distributed to hospitals and over-the-counter pharmacies through provincial and municipal pharmaceutical logistics companies.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NYSE-CPHI
|
—
|
—
|
—
|
—
|
—
|
—
|
Fair
|
—
|
—
|
—
|
0.0%
|
August 14, 2026
|
-10.4x
|
1.0x
|
9.2x
|
36.875 M
|
40.563 M
|
9.5%
|
2.0%
|
-25.2
|
—
|
-4.7%
|
